Concepedia

Johannes Pöhlmann

JP

9

Publications

194

Citations

9

H-Index

2017

Active since

Affiliations

Covalence Research(Current)

Roche (Switzerland)

Novo Nordisk (Denmark)

Novo Nordisk (United Kingdom)

Johannes Pöhlmann is an author at Covalence Research specializing in clinical trials, pharmacotherapy, and diabetes.

ORCID

Top concepts

Publications per year

2017–2024

9

Publications

9

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

Johan Jendle, Johannes Pöhlmann, Simona de Portu et al. · Diabetes Technology & Therapeutics · 2019 · 51 citations

Mixture Cure Models in Oncology: A Tutorial and Practical Guidance

Federico Felizzi, Noman Paracha, Johannes Pöhlmann et al. · PharmacoEconomics - Open · 2021 · 39 citations · Full text

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma

Johannes Pöhlmann, Michael Weller, Andrea Marcellusi et al. · Frontiers in Oncology · 2024 · 20 citations · Full text

Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain

Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Nana Kragh et al. · Diabetes Therapy · 2017 · 19 citations · Full text

Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis

Johannes Pöhlmann, Beth Mitchell, Sanjay Bajpai et al. · Journal of Diabetes Science and Technology · 2019 · 15 citations · Full text

Rows per page

1–5 of 9